Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 423

1.

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.

Richie JP, Catalona WJ, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al.

Urology. 1993 Oct;42(4):365-74.

PMID:
7692657
2.

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al.

J Urol. 1994 May;151(5):1283-90.

PMID:
7512659
3.

Clinical usefulness of free PSA in early detection of prostate cancer.

Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H; Early Detection Project Group of the German Society of Urology.

Onkologie. 2001 Feb;24(1):33-7.

PMID:
11441278
4.
5.

Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.

Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L.

Urology. 1996 May;47(5):699-703.

PMID:
8650868
6.

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

Catalona WJ, Hudson MA, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al.

J Urol. 1994 Dec;152(6 Pt 1):2037-42.

PMID:
7525995
7.

Prostate cancer screening: role of the digital rectal examination and prostate-specific antigen.

Richie JP, Kavoussi LR, Ho GT, Vickers MA, O'Donnell MA, St Laurent D, Chen A, Goldstein DS, Loughlin KR.

Ann Surg Oncol. 1994 Mar;1(2):117-20.

PMID:
7530587
8.
9.

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.

Southwick PC, Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Parson RE, Loveland KG.

J Urol. 1999 Oct;162(4):1346-51.

PMID:
10492194
10.

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.

Urology. 1999 May;53(5):945-50.

PMID:
10223488
11.

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.

Horninger W, Cheli CD, Babaian RJ, Fritsche HA, Lepor H, Taneja SS, Childs S, Stamey TA, Sokoll LJ, Chan DW, Brawer MK, Partin AW, Bartsch G.

Urology. 2002 Oct;60(4 Suppl 1):31-5.

PMID:
12384160
12.

Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.

Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.

J Urol. 2001 Oct;166(4):1339-42.

PMID:
11547069
13.

Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.

Luboldt HJ, Bex A, Swoboda A, Hüsing J, Rübben H; Early Detection Project Group of the German Urological Association.

Eur Urol. 2001 Feb;39(2):131-7.

PMID:
11223671
14.

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.

Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R.

Urology. 2001 Jan;57(1):83-90.

PMID:
11164149
15.

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC.

J Urol. 1994 Dec;152(6 Pt 1):2031-6.

PMID:
7525994
16.

Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.

Carvalhal GF, Smith DS, Mager DE, Ramos C, Catalona WJ.

J Urol. 1999 Mar;161(3):835-9.

PMID:
10022696
17.

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J, Brousseau G, Bélanger A, Labrie F.

Prostate. 2000 Sep 15;45(1):19-35.

PMID:
10960839
18.

Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.

Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G.

Cancer. 1997 Nov 1;80(9):1818-29.

PMID:
9351555
19.

Significance of free prostate-specific antigen and gamma-seminoprotein in the screening of prostate cancer.

Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T.

Prostate Suppl. 1996;7:40-7.

PMID:
8950363

Supplemental Content

Support Center